Expanded US GDP Net Annual Benefit $106.2B $23.6B The medical technologies studied generated economic returns that were substantially greater than their costs, meaning that advanced medical devices and diagnostics not only bring immense benefit to individual patients, but a brighter economic future for the country as a whole. Continued investment in medical devices and diagnostics, and policies that support enhanced investment, will generate even larger net savings over time. Conversely, reduced incentives will result in large net costs. $150,365 annual savings /person affected $1.8B increased tax revenue COLORECTAL CANCER Sigmoidoscopy/Colonoscopy DIABETES Insulin Pump use $5,886 annual savings /person affected $34.9M increased tax revenue $24,518 annual savings /person affected $3.8B increased tax revenue MUSCULOSKELETAL DISEASE MRI & Joint Replacement Surgery $1,930 annual savings /person affected $1.5B increased tax revenue HEART DISEASE Diagnostic/Angioplasty/ Pacemaker use INCREASED INCENTIVES FOR MEDICAL TECHNOLOGY INVESTMENT WILL GENERATE EVEN LARGER NET SAVINGS OVER TIME. REDUCED INCENTIVES FOR MEDICAL TECHNOLOGY WILL RESULT IN LARGER NET COSTS. FUTURE HEALTH SYSTEM & ECONOMIC SAVINGS GAIN 2010 2015 2020 2025 2030 2035 0.00 0.00 26.43 65.73 103.10 144.24 192.51 $ billions 200 160 120 80 40 0 WHAT THIS STUDY MEANS LOSS $3.4T 2010 2015 2020 2025 2030 2035 -650.47 -393.41 -230.53 -123.28 -44.39 $ billions 0 -100 -200 -300 -400 -500 -600 -700 $1.4T THE USE OF KEY MEDICAL TECHNOLOGIES IN FOUR DISEASE AREAS EXPANDED U.S. GDP BY $106.2B IN 2010 AND PROVIDED A NET ANNUAL BENEFIT OF $23.6 B TO THE ECONOMY HEALTHY SAVINGS: MEDICAL TECHNOLOGY & THE ECONOMIC BURDEN OF DISEASE Study by Milken Institute. Authors: Anusuya Chatterjee, Jaque King, Sindhu Kubendran, and Ross DeVol. To view the full study, visit: http://lifechanginginnovation.org/get-facts